Primary |
Hypertension |
65.0% |
Prophylaxis |
10.0% |
Asthma |
5.0% |
Asthmatic Crisis |
5.0% |
Dyslipidaemia |
5.0% |
Hypothyroidism |
5.0% |
Type 1 Diabetes Mellitus |
5.0% |
|
Femoral Neck Fracture |
25.0% |
Blood Pressure Diastolic Decreased |
12.5% |
Blood Pressure Inadequately Controlled |
12.5% |
Cholecystitis |
12.5% |
Death |
12.5% |
Diabetes Mellitus |
12.5% |
Myocardial Infarction |
12.5% |
|
Secondary |
Hypertension |
21.1% |
Blood Pressure Increased |
8.9% |
Anxiety |
7.8% |
Rheumatoid Arthritis |
7.8% |
Suicide Attempt |
7.8% |
Depression |
4.4% |
Diabetes Mellitus |
4.4% |
Lyme Disease |
4.4% |
Migraine |
4.4% |
Muscle Spasms |
4.4% |
Pain |
4.4% |
Product Used For Unknown Indication |
3.3% |
Blood Cholesterol Abnormal |
2.2% |
Drug Withdrawal Maintenance Therapy |
2.2% |
Dysuria |
2.2% |
Fungal Infection |
2.2% |
Hypercholesterolaemia |
2.2% |
Prophylaxis |
2.2% |
Reflux Oesophagitis |
2.2% |
Atrial Fibrillation |
1.1% |
|
Completed Suicide |
8.7% |
Death |
8.7% |
Prostate Cancer |
8.7% |
Aortic Valve Incompetence |
4.3% |
Arthralgia |
4.3% |
Blood Catecholamines Increased |
4.3% |
Blood Pressure Inadequately Controlled |
4.3% |
Coma |
4.3% |
Dizziness |
4.3% |
Hemiplegia |
4.3% |
Hepatic Fibrosis |
4.3% |
Hypotension |
4.3% |
Hypothermia |
4.3% |
Oedema Peripheral |
4.3% |
Orthostatic Hypotension |
4.3% |
Skin Plaque |
4.3% |
Throat Tightness |
4.3% |
Tongue Oedema |
4.3% |
Toxicity To Various Agents |
4.3% |
Transaminases Increased |
4.3% |
|
Concomitant |
Hypertension |
33.3% |
Diabetes Mellitus |
7.2% |
Prostate Cancer |
7.2% |
Type 2 Diabetes Mellitus |
5.4% |
Blood Cholesterol Increased |
5.0% |
Induction Of Anaesthesia |
3.6% |
Atrial Fibrillation |
3.2% |
Benign Prostatic Hyperplasia |
3.2% |
Depression |
3.2% |
Neuralgia |
3.2% |
Premedication |
3.2% |
Thrombosis Prophylaxis |
3.2% |
Colon Cancer |
2.7% |
Gastrooesophageal Reflux Disease |
2.7% |
Hypercholesterolaemia |
2.7% |
Sleep Disorder |
2.7% |
Hypothyroidism |
2.3% |
Osteoporosis |
2.3% |
Pain |
2.3% |
Arrhythmia |
1.8% |
|
Pneumonia |
8.9% |
Weight Increased |
8.9% |
Cerebrovascular Accident |
7.1% |
Hypertension |
7.1% |
Malaise |
7.1% |
Septic Shock |
7.1% |
Nervousness |
5.4% |
Renal Impairment |
5.4% |
Anaphylactic Shock |
3.6% |
Cholestasis |
3.6% |
Death |
3.6% |
Gait Disturbance |
3.6% |
Hyperglycaemia |
3.6% |
International Normalised Ratio Increased |
3.6% |
Pain |
3.6% |
Presyncope |
3.6% |
Renal Failure |
3.6% |
Swelling |
3.6% |
Vestibular Disorder |
3.6% |
Visual Acuity Reduced |
3.6% |
|
Interacting |
Hypertension |
79.3% |
Peripheral Arterial Occlusive Disease |
20.7% |
|
Syncope |
66.7% |
Aortic Valve Sclerosis |
16.7% |
Sinus Bradycardia |
16.7% |
|